Table 2.
Summarizing targeted therapies for HPV specifically aimed at reducing cardiac diseases.
| Therapy | Mechanism of Action | Potential Impact on Cardiac Diseases |
|---|---|---|
| Antiviral Agents | Inhibit HPV replication and spread60 | Potential reduction in HPV-related inflammation, possibly reducing cardiac complications associated with HPV. |
| Immunotherapy | Boost the immune response against HPV.61 | Strengthened immune defense might limit HPV-related cardiac inflammation. |
| Vaccination | Preventive measure against HPV infection.62 | Reduction in HPV incidence could lower the risk of subsequent cardiac diseases related to persistent HPV. |
| Anti-inflammatory Agents | Target inflammation caused by HPV infection63 | Reduction in systemic inflammation, potentially benefiting cardiac health. |
| Antioxidants | Combat oxidative stress linked to HPV64 | Minimization of oxidative damage, potentially reducing cardiac complications associated with HPV-induced inflammation. |
| Regular Screening And Management | Early detection of HPV and related complications. | Prompt intervention and management could prevent or mitigate cardiac issues. |
| Lifestyle Modifications | Healthy diet, exercise, and stress management. | Strengthen overall immune response, potentially reducing HPV-related cardiac complications. |